Next Quarterly Earnings
Wednesday, November 4, 2026
CW 45
Pre-Market
In 69 days
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
United Therapeutics Corporation
United Therapeutics Corporation is a U.S. biopharmaceutical company dedicated to developing innovative therapies for patients with life-threatening diseases. A primary focus is on lung diseases such as pulmonary arterial hypertension (PAH) and improving organ transplantation. The company researches and develops groundbreaking medicines to extend and improve the lives of its patients.
Frequently asked questions
When will United Therapeutics Corporation report its next quarterly earnings?
United Therapeutics Corporation is scheduled to report its next quarterly earnings on 11/04/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
When did United Therapeutics Corporation last report quarterly earnings?
United Therapeutics Corporation last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 7.27 USD.
How does United Therapeutics Corporation stock react to earnings?
Across its last 3 earnings reports, United Therapeutics Corporation stock moved by ±9% on average the following day. The largest reaction was +13% on 02/25/2026; 3 of 3 reactions were positive.
How often has United Therapeutics Corporation beaten expectations?
United Therapeutics Corporation has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
How do I add the United Therapeutics Corporation earnings dates to my calendar?
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
All Dates
Earnings statistics
Stock reaction to earnings
±9%
Avg. next-day move
+13%
Largest move (02/25/2026)
100%
Share of positive reactions
±4.2%
Avg. move after 7 days
Basis: price reactions to the last 3 report dates (close to close).
Estimates vs. results
3/5
Quarters above estimates
60%
Beat rate
-0.6%
Avg. EPS surprise
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.
Company Information
Name
United Therapeutics Corporation
Country
🇺🇸
More Financial Information